Genome wide association studies in inflammatory myopathy and

More documents

Recommendations

Info

GWAS approaches (2) • Further assessments on the DM GWAS data for 140 non-MHC SNPs previously associated with AID (RA, SLE, Crohn’s, type 1 Diabetes & Multiple Sclerosis). 18
Covariate 2 Multidimensional scaling analysis of European PM/DM GWAS data MDS Dimensions 1 and 2 0.015 0.01 0.005 0 -0.02 -0.01 0 0.01 0.02 0.03 0.04 0.05 Covariate 1 -0.005 Czech (117) -0.01 Hungary (89) Netherlands (27) -0.015 Sweden (79) UK (319) -0.02 -0.025
Page 1 and 2: IIM GWAS reveals genetic risk facto
Page 3 and 4: Polymyositis Dermatomyositis Idiopa
Page 5 and 6: Early genetics - HLA region
Page 7 and 8: Classification of myositis accordin
Page 9 and 10: UK-Adult Onset Myositis Immunogenet
Page 11 and 12: log OR & 95% confidence interval HL
Page 13 and 14: Myositis-specific autoantibodies My
Page 15 and 16: Dermatomyositis (DM) • Myositis w
Page 17: GWAS approaches 1 • MYOGEN (UK/EU
Page 21 and 22: Populations Studied Cases Controls
Page 23 and 24: Published GWAS loci for AID - Assoc
Page 25 and 26: • The first GWAS in DM confirmed
Page 27 and 28: Total number of participants recrui
Page 29: • Hector Chinoy - Musculoskeletal

Genome wide association studies in inflammatory myopathy and

Create successful ePaper yourself

Delete template?

Save as template?